Recombinant CD22 (Pinatuzumab Biosimilar) antibody

Catalog No. ABIN7093048

The Humanized Monoclonal anti-CD22 (Pinatuzumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect CD22 (Pinatuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD22 (Pinatuzumab Biosimilar) antibody (ABIN7093048)

Target: CD22 (Pinatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD22 (Pinatuzumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-CD22 (Pinatuzumab Biosimilar) Antibody

Purpose: Anti-CD22 (pinatuzumab biosimilar) mAb

Characteristics: ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CD22 (Pinatuzumab Biosimilar)

Target: CD22 (Pinatuzumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: CD22, SIGLEC2, BL-CAM, SIGLEC-2, Siglec2, SIGLEC2FLJ22814

Gene ID: 933

UniProt: P20273